Precision Value & Health acquires Across Health

Pharma marketing specialist Precision Value & Health has acquired the specialist communications consultancy Across Health.

Across Health is a leading global omnichannel engagement consultancy focused on providing clients an analytical and evidence-based framework for commercial strategy, execution, and resource optimisation.

The company’s solutions are based around its proprietary Navigator365 product suite, which more than 40 pharmaceutical companies rely on for omnichannel planning and resource allocation.

The Across Health team is already working hand-in-hand with Precision’s medical communications, creative, and data sciences teams to offer analytically driven launch and marketing programs across the product life cycle.

Founded in 2008 and headquartered in Belgium, Across Health partners with blue-chip life science clients to design, execute, and track omnichannel strategies and digital transformation programs.

The foundation of Across Health’s solutions is their market-leading Navigator365 product suite, a platform for omnichannel launch planning, campaign strategy formulation, resource allocation, and impact measurement.

These innovative products are complemented by decades of deep industry consulting expertise that helps clients develop a measurably effective omnichannel strategy – for launch, and throughout the entire commercialization life cycle.

Precision Value & Health’s EVP, physician and patient engagement, Carolyn Morgan said: “The cultural fit between our teams was immediate and collaboration began almost instinctively.

“Across Health is built around a family of proprietary products that helps clients optimise their go-to-market strategy and resources using a uniquely actionable analytical framework.

“Their expertise, plus the Navigator365, allows us to step into a new level of evidence-based omnichannel customer engagement that will drive better decision making, and even greater success, for our clients.”

Across Health’s founder and CEO, Fonny Schenck said: “For years we have honed our pragmatic, evidence-based, end-to-end products and consultative insights to accelerate digital transformation and optimize the omnichannel go-to-market model for leading life science companies.”

 

Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.